Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
Bausch & Lomb 和 Edgewise Therapeutics 是上週中市股票漲幅最高的前7只股票(9月15日至9月21日):其他的股票在您的投資組合中嗎?
This week, the Federal Reserve's decision to reduce interest rates by 50 basis points boosted share prices across the technology, construction, industrial, machinery, and financial sectors.
本週,聯儲局決定將利率下調50個點子,提振了科技、施工、工業、機械和金融行業的股價。
These seven mid-cap stocks were the best performers in the last week. Are they in your portfolio?
這七隻中型股票是上週表現最好的股票。 你的投資組合裏有嗎?
- Edgewise Therapeutics, Inc. (NASDAQ:EWTX) shares rocketed 50.19% after the company announced topline data of EDG-7500 from the Phase 1 trial in healthy subjects and the single-dose arm of the Phase 2 CIRRUS-HCM trial in patients with obstructive HCM.
- Bausch + Lomb Corporation (NYSE:BLCO) stock gained 28.36% after reportedly considering a sale.
- Bausch Health Companies Inc. (NYSE:BHC) shares upped 27.06%. The company's subsidiary Bausch + Lomb Corp (NYSE:BLCO) is reportedly considering a sale.
- Ascendis Pharma A/S (NASDAQ:ASND) stock gained 26.87% last week after the company announced topline data from its pivotal approach trial of a rare dwarfism candidate.
- Nuvalent Inc.'s (NASDAQ:NUVL) stock gained 23.50% after the company highlighted results for its ROS1 and ALK-Positive NSCLC programs and accelerated its development timeline. The company also announced a $350 million public offering, and multiple firms raised their respective price forecasts on the stock.
- Powell Industries, Inc. (NASDAQ:POWL) stock gained 22.61% last week as stocks in the broader industrial space jumped following the Fed's announcement to cut rates by 50 basis points, which could support investment and economic growth.
- GDS Holdings Limited (NASDAQ:GDS) shares jumped 21.28%.
- Edgewise Therapeutics, Inc.(納斯達克股票代碼:EWTX)股價飆升50.19%,因公司宣佈EDG-7500藥物在健康受試者的1期試驗和患有梗阻型HCm的2期CIRRUS-HCm試驗單劑組的結果數據。
- Bausch + Lomb Corporation(紐交所股票代碼:BLCO)股票上漲28.36%,據報道正在考慮出售。
- Bausch Health Companies Inc.(紐交所股票代碼:BHC)股價上漲27.06%。該公司子公司Bausch + Lomb Corp(紐交所股票代碼:BLCO)據稱正在考慮出售。
- Ascendis Pharma A/S(納斯達克股票代碼:ASND)股價上漲26.87%,公司宣佈其罕見侏儒症候選藥試驗的重要數據。
- Nuvalent Inc.(納斯達克股票代碼:NUVL)股價上漲23.50%,因公司突出其ROS1和ALk陽性NSCLC項目的結果,加快了其發展進度。該公司還宣佈了3.5億美元的公開募股,多家公司提高了對該股的價格預測。
- Powell Industries, Inc.(納斯達克股票代碼:POWL)股價上漲22.61%,上週工業股更廣泛的股票在聯邦快遞宣佈削減50個點子的利率期貨後上漲,這可能支持投資和經濟增長。
- 萬國數據有限公司 (納斯達克: 納斯達克) 股票上漲了21.28%。
Also Read:
還閱讀:
- Constellation Energy, Li Auto And Carvana Are Among Top 11 Large Cap Gainers Last Week (Sept 16-Sept 20): Are The Others In Your Portfolio?
- Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
- 在上週(9月16日-9月20日)中,星座能源、理想汽車和carvana是大盤表現最強的前11名股票收益者,您的投資組合中還有其他股票嗎?
- 諾和諾德、chewy和聯邦快遞是上週(9月15日-9月21日)大盤前10名的輸家:您的投資組合中還有其他公司嗎?
Photo by JHVEPhoto via Shutterstock
照片由JHVEPhoto通過Shutterstock提供
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。